On this page
- What the research is actually about
- What little human evidence exists
- Why ligaments are hard to treat this way
- Partial tears and sprains are a different question
- The anterior cruciate ligament specifically
- How a ligament is supposed to heal
- What a clinic can honestly offer
- Risks and costs
- Questions worth asking
- Frequently asked questions
- Requesting a medical evaluation
Ligaments connect bone to bone and take the load when a joint is pushed to its limit. When one tears badly, the standard answers are rehabilitation or reconstruction. Stem cell therapy for ligament injuries is presented as a third option, and the honest position is that the human evidence for it barely exists yet.
What the research is actually about
A systematic review of this field is a review of preclinical scaffold work — Preclinical Studies on Biomaterial Scaffold use in Knee Ligament Regeneration: A Systematic Review.
Preclinical means before human use. It means cell culture and animal models, and the word appears in that title because the authors were describing exactly that.
A related body of work covers tissue engineering approaches for reconstructive surgery — Tissue engineering of ligaments for reconstructive surgery — which is laboratory construction of ligament substitutes, not an injection you can book.
What the evidence levels mean explains why this page is graded the way it is.
What little human evidence exists
A clinical-evidence review has covered cells in tendon and ligament injury together — Mesenchymal Stem Cells for Treatment of Tendon and Ligament Injuries-clinical Evidence.
Grouping tendon with ligament is itself revealing. They are different tissues doing different jobs, and they are combined in reviews because neither has enough studies on its own to review separately.
Most of what exists within that is tendon work. See tendon injury, which is graded the same way and for the same reason.
Why ligaments are hard to treat this way
A torn ligament is a mechanical failure. The two ends are apart, often retracted, and the joint is unstable under load.
Cells do not span a gap. Whatever biological signalling an injection provides, it does not bring separated ends together or restore tension across a joint.
This is why the laboratory work is about scaffolds — a physical structure for cells to grow along. Without that structure, there is no reported mechanism by which an injection reconstructs a torn ligament.
Partial tears and sprains are a different question
Most ligament injuries are sprains — stretched or partially torn fibres that remain in continuity. Those heal on their own, given time and appropriate loading.
Because they heal anyway, an uncontrolled treatment given during that window will appear to work. Every patient improves. Attributing that improvement to the injection requires a control group, and for ligaments those controls have not been run.
This is the single most important thing to understand before paying for treatment of a sprain.
The anterior cruciate ligament specifically
The ACL is the ligament people most often ask about, and it is the least forgiving. A complete tear in the mid-substance does not heal, because the ligament sits inside the joint bathed in synovial fluid, which disrupts clot formation.
Reconstruction using a graft is the established treatment for patients who need a stable knee for their activity. It has decades of outcome data behind it.
No published human trial supports injected cells as an alternative to that. Where cells appear in ACL research, it is as an addition to a surgical repair or reconstruction.
There is renewed surgical interest in repairing rather than replacing certain ACL tears, using a scaffold to hold a clot in place while the ligament heals to itself. That work is surgical, it is specific to a subset of tears close to the bone, and it is not what is being sold when a clinic offers an injection for a cruciate tear.
How a ligament is supposed to heal
Ligaments outside a joint capsule — the medial collateral ligament of the knee is the usual example — have a blood supply and heal reliably. A graded rehabilitation programme is the treatment, and the results are good.
Healing runs through inflammation, then new collagen laid down in a disorganised pattern, then slow remodelling of that collagen along lines of stress. The remodelling phase takes months and depends on controlled loading. Rest alone produces a weaker ligament than progressive loading does.
That sequence is why timing matters more than any injection. A treatment given during the remodelling phase, in a patient who is also rehabilitating properly, is almost impossible to separate from the rehabilitation itself without a control group.
What a clinic can honestly offer
An assessment, imaging review, and a straight answer about whether your injury is one that heals, one that needs reconstruction, or one where a trial of injection is a reasonable gamble with clearly stated odds.
For most ligament injuries that answer will be rehabilitation or surgery. A clinic that agrees with that is being straight with you.
The patient journey describes what an assessment should involve, including the possibility that the answer is no.
Risks and costs
The procedural risks are the ordinary ones: infection, injection-site pain, harvest-site complications where your own cells are used.
The larger risk here is opportunity cost. Time spent on an unproven injection is time an unstable knee spends unstable, and secondary meniscal and cartilage damage accumulates in that period.
Meniscus injury is a common consequence of prolonged instability, which is one reason delay is not neutral.
Questions worth asking
- Which human trial in ligament injury supports this, and how many patients were in it?
- Is my tear complete or partial, and would it heal without treatment?
- What would a knee surgeon say about this injury?
- What is the plan if the joint remains unstable?
If the answer to the first question is a preclinical review or a tendon study, you have your answer about where this sits. The limits of current evidence covers the general shape of that problem.
Frequently asked questions
Can stem cells repair a torn ACL?
No human trial supports that. The laboratory work in this area is about scaffolds, because cells alone do not span a gap between separated ends.
What about a partial tear?
Partial tears generally heal on their own, which makes uncontrolled treatment look effective. Controlled trials in ligament injury have not been done.
Why is this graded preclinical?
Because the systematic reviews in this area describe themselves as preclinical — laboratory and animal work, before human use.
Is it worth trying before surgery?
For an unstable knee, delay carries its own cost in secondary joint damage. That trade-off should be discussed openly before you decide.
Clinics advertise this. Why?
Demand exists and the treatment is easy to provide. Neither fact creates evidence, which is why this page is graded the way it is.
Does PRP work better for ligaments?
It has been studied more in tendon than ligament, and the results there are mixed. It is a different product, not a stronger version of the same one.
Requesting a medical evaluation
Nothing on this page establishes whether any treatment is appropriate for you. That needs your history, your imaging and your current medications read by a clinician. If you would like that review, send your records and we will tell you honestly whether there is anything worth discussing — including when the answer is no.
This page is general information, not medical advice, and does not create a doctor–patient relationship. Regenerative treatments discussed here are in most cases investigational. Discuss any treatment with a clinician who knows your history.